AIF · Equity · CAT III - LONG ONLY
Sanhit India Momentum Fund
IRRSince inception12.98%
Minimum investment₹1 Crore
3Y return–
Fund age11 mo
Growth of₹Cr
Sanhit India Momentum
Returns: How it has done
| Scheme / Benchmark | YTD | 1Y | 2Y | 3Y | 5Y | Since inception |
|---|---|---|---|---|---|---|
| Sanhit India Momentum | 13.35% | — | — | — | — | 12.98% |
| NIFTY 500 Index | −1.02% | — | — | — | — | 2.76% |
| Excess over benchmark | 14.37% | — | — | — | — | 10.22% |
Returns up to one year are absolute; two years and above are annualised (CAGR). YTD is calendar-year-to-date. As on 31 Aug 2026.
Risk : What you take on to earn the return
Volatility
10.19%
A standard deviation reflecting historical swings.
Risk-reward
0.93
Sharpe
Excess return gained per unit of volatility.
How far below its previous high it fell
Over the trailing 1Y window the scheme fell −5.02%, and recovered on 30 Apr 2026.
Max drawdowns
−5.02%
Scheme Drawdown Trajectory
| Drawdown analysis | Peak | Trough | Depth | Fell over | Recovered | Recovery took |
|---|---|---|---|---|---|---|
| Scheme | – | – | −5.02% | – | 30 Apr 2026 | – |
| Benchmark | 05 Sep 2025 | 30 Mar 2026 | −14.69% | 206 days | – | – |
Scheme
Peak–
Trough–
Depth−5.02%
Fell over–
Recovered30 Apr 2026
Recovery took–
Benchmark
Peak05 Sep 2025
Trough30 Mar 2026
Depth−14.69%
Fell over206 days
Recovered–
Recovery took–
The benchmark's peak, trough and recovery are read off its month-end curve; the scheme's row is measured on daily NAV. · Risk and drawdown use a trailing 1Y window · As on 31 Aug 2026
Portfolio Details : Where the money actually sits
Asset class
Equity
Top 5 holdings
Torrent Pharmaceuticals Ltd4.40%
Laurus Labs Ltd2.83%
Granules India Ltd2.51%
Syrma SGS Technology Ltd2.50%
Gabriel India Ltd2.44%
Let's start a
conversation
conversation
- Compare this AIF against 3,000+ others with our research desk
- Build a long-term portfolio around your goals, not a one-off buy
- Experts with decades of experience.
Private. Personal. No obligation.
We will only use these details to contact you about this enquiry. No spam.